Discover

ATNM
Actinium Pharmaceuticals, Inc.
0.98
400 x undefined
300 x undefined
bid
ask
-
0.00
0.02%
350 @ 04:00 PM
1.00 +0.02 (1.91%)
Ytd-27.96%
1y-27.42%
0.97
day range
0.99
0.94
52 week range
1.89
Open0.97Prev Close0.98Low0.97High0.99Mkt Cap30.74M
Vol90.78KAvg Vol180.83KEPS-0.76P/EN/AForward P/E-1.77
Beta0.15Short Ratio5.72Inst. Own30.11%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0850-d Avg1.15200-d Avg1.291yr Est5.00

ATNM News

benzinga.com
Actinium's ATNM-400 Reports Preclinical Activity And Combination Synergy Across KRAS- And EGFR-Mutan

New KRAS-mutant data show ATNM-400 outperformed standard-of-care inhibitors sotorasib and adagrasib

benzinga.com
Actinium Pharma Presents New Data On ATNM-400 In Prostate Cancer At SNMMI 2026 Annual Meeting

New data demonstrated ATNM-400 remains potently active in prostate cancer cells and tumors resistant

benzinga.com
Actinium Pharmaceuticals Obtains Two Patent Allowances Spanning Its Actimab-A And Iomab-ACT Programs

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of

benzinga.com
Actinium Pharmaceuticals To Reveal ATNM-400 Program Update At SNMMI 2026 Conference on May 31-June 2

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of

benzinga.com
Actinium Highlights Data Presented At AACR Supporting Transcriptional Reprogramming As Central Mecha

Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, indepen

benzinga.com
Actinium Pharma Presents Preclinical Results For ATNM-400 Across Prostate, Lung, And Breast Cancer M

ATNM-400 demonstrates pan-tumor activity across prostate, lung, and breast cancer models, supporting

benzinga.com
Stephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

Stephens & Co. analyst Sudan Loganathan reiterates Actinium Pharma (AMEX:ATNM) with a Overwei

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023

benzinga.com
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on M

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's session, 445 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

Tuesday morning saw 181 companies set new 52-week highs.

benzinga.com
81 Biggest Movers From Yesterday

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares climbed 112.5% to close at $7.80 on

benzinga.com
64 Stocks Moving In Monday's Mid-Day Session

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 218% to $11.67 after gaining

benzinga.com
31 Stocks Moving in Monday's Pre-Market Session

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 184% to $10.41 in pre-market t

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

On Tuesday, 225 companies set new 52-week highs.

benzinga.com
60 Stocks Moving In Thursday's Mid-Day Session

Gainers Cinedigm Corp. (NASDAQ: CIDM) shares jumped 201.5% to $3.95 after the company announced i

benzinga.com
38 Biggest Movers From Yesterday

38 Biggest Movers From Yesterday

benzinga.com
28 Stocks Moving In Monday's Mid-Day Session

28 Stocks Moving In Monday's Mid-Day Session